Compare RSKD & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RSKD | DNA |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | United States |
| Employees | N/A | 485 |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 686.4M | 599.0M |
| IPO Year | 2021 | N/A |
| Metric | RSKD | DNA |
|---|---|---|
| Price | $5.02 | $7.40 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 2 |
| Target Price | $5.96 | ★ $8.50 |
| AVG Volume (30 Days) | 906.7K | ★ 1.1M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.09 | N/A |
| Revenue Next Year | $10.08 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.70 | $5.37 |
| 52 Week High | $5.49 | $17.58 |
| Indicator | RSKD | DNA |
|---|---|---|
| Relative Strength Index (RSI) | 48.26 | 35.71 |
| Support Level | $4.73 | $7.40 |
| Resistance Level | $5.28 | $10.27 |
| Average True Range (ATR) | 0.14 | 0.56 |
| MACD | -0.03 | -0.21 |
| Stochastic Oscillator | 24.69 | 2.77 |
Riskified Ltd offers an AI-powered e-commerce risk intelligence platform that identifies the individual behind each online interaction for legitimacy, helping merchants (its customers) eliminate risk and uncertainty from their business. The company's core product, the Chargeback Guarantee, automatically approves or declines online orders with performance levels that vary in accordance with its merchants' priorities. Additionally, it offers other products that mitigate similar e-commerce risks for those same merchants, including Policy Protect, Dispute Resolve, and Account Secure. Geographically, Riskified generates maximum revenue from the United States, and the rest from other regions of the Americas, Europe, the Middle East and Africa (EMEA), and the Asia-Pacific (APAC) region.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.